An Overview of Poly(lactic-co-glycolic) Acid (PLGA)-Based Biomaterials for Bone Tissue Engineering
By P. Gentile, V. Chiono, I. Carmagnola, P. Hatton. International Journal of Molecular Sciences, 2014
1,385 citations recorded by the source corpus.
Poly(lactic-co-glycolic) acid (PLGA) has attracted considerable interest as a base material for biomedical applications due to its: (i) biocompatibility; (ii) tailored biodegradation rate (depending on the molecular weight and copolymer ratio); (iii) approval for clinical use in humans by the U.S. Food and Drug Administration (FDA); (iv) potential to modify surface properties to provide better interaction with biological materials; and (v) suitability for export to countries and cultures where implantation of animal-derived products is unpopular. This paper critically reviews the scientific challenge of manufacturing PLGA-based materials with suitable properties and shapes for specific biomedical applications, with special emphasis on bone tissue engineering. The analysis of the state of the art in the field reveals the presence of current innovative techniques for scaffolds and material manufacturing that are currently opening the way to prepare biomimetic PLGA substrates able to modulate cell interaction for improved substitution, restoration, or enhancement of bone tissue function.
Subfields: Biomaterials, Biomedical Engineering
View Paper: https://www.semanticscholar.org/paper/ef4922c35f5646c8309df20821e1bcaddce30e75
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- W. Shu
- J. Clarke
- G. Turnbull
- P. Riches
- Bin Li
- Luanluan Jia
- F. Picard
- F. Han
Citations in the corpus
- 3D bioactive composite scaffolds for bone tissue engineering (2017, background): “PLGA also potentially balances the limitations of nHA which include inherent brittleness and slow degradation [318,323].”